跳至主要内容
临床试验/CTRI/2024/04/065623
CTRI/2024/04/065623尚未招募2/3 期

Efficacy of Immersive Virtual Reality and Cognitive Training on various parameters in patients suffering from Alzheimers Disease:A Randomized Controlled Trial

Reena Kumari1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年5月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
Global cognitive function measured using montral cognitive scale

研究概览

简要总结

AD has become a significant problem for the health system, imposing a heavy burden both financially and psychologically on a global scale. Numerous studies have been done to find out the effects of immersive virtual reality on cognitive impairment in conditions such as Stroke, Parkinson’s disease, Traumatic brain injury, and Mild cognitive impairment, but only a few studies have been done on finding feasibility and role of play activities in AD. To my knowledge there is no study to find the efficacy of IVR training for people suffering from AD. Available literature suggests that no studies have been done on the Indian population which needs further investigation. The main Aim of the study is to assess the effect of Immersive Virtual Training and Cognitive Training on the Global cognitive function, Instrumental activities of daily living (IADL’S), Quality of life (QOL) and Brain activities in patients with mild to moderate Alzheimer’s disease. Participants will be recruited from various hospitals and community centres. Participants will be screened on the basis of inclusion criteria. Whole experimental procedure will be explained and informed consent will be obtained from the participants prior to commencement of the study. Participants will be randomly assigned into 2 Experimental groups and 1 Control group. Data will be taken before and after the completion of training protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
60.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • patients older than 60 years with diagnosis of AD, consent in participation,absence of vision and hearing impairment likely to effect social life,ability to read and write.

排除标准

  • Patients who have major neurological or psychiatric conditions that may affect cognition (e.g., Parkinson’s disease, Stroke, Schizophrenia) 2)Patients who are unable to comply with the training regimen 3)Patients with visual, vestibular, and auditory impairments 4)Severe orthopaedic impairments.

结局指标

主要结局

Global cognitive function measured using montral cognitive scale

时间窗: at baseline and after 8 weeks

Brain activities measured using Electroencephalogram (EEG)

时间窗: at baseline and after 8 weeks

次要结局

  • Activities of Daily Living measured by Instrumental activities of daily living scale (IADLS)(Quality of Life measured by Quality of Life in Alzheimer’s Disease)

研究者

发起方
Reena Kumari
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Reena Kumari

Guru Jambheshwar University of Science and Technology,Hisar,Haryana

研究点 (1)

Loading locations...

相似试验